Bial has proudly launched KYNMOBI® (Apomorphine Hydrochloride) in the United Kingdom, offering a groundbreaking new treatment for patients with Parkinson’s disease experiencing OFF episodes. This thrilling introduction marks a significant milestone in broadening Bial’s innovative portfolio